Molecular imaging of protein kinase activity and its application in diseases

S I Reed, Control of the G1/S transition. Cancer surveys. ,vol. 29, pp. 7- 23 ,(1997)

Ravi Tolwani, Akiko Sato, Brenda Klaunberg, In vivo bioluminescence imaging. Comparative Medicine. ,vol. 54, pp. 631- 634 ,(2004)

Patrick C Ma, Gautam Maulik, James Christensen, Ravi Salgia, c-Met: Structure, functions and potential for therapeutic inhibition Cancer and Metastasis Reviews. ,vol. 22, pp. 309- 325 ,(2003) , 10.1023/A:1023768811842

Michael B Yaffe, German G Leparc, Jack Lai, Toshiyuki Obata, Stefano Volinia, Lewis C Cantley, None, A motif-based profile scanning approach for genome-wide prediction of signaling pathways Nature Biotechnology. ,vol. 19, pp. 348- 353 ,(2001) , 10.1038/86737

Jeroen den Hertog, Arne Östman, Frank-D. Böhmer, Protein tyrosine phosphatases: regulatory mechanisms. FEBS Journal. ,vol. 275, pp. 831- 847 ,(2008) , 10.1111/J.1742-4658.2008.06247.X

K E Rosenzweig, B D Price, S T Palayoor, M B Youmell, Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clinical Cancer Research. ,vol. 3, pp. 1149- 1156 ,(1997)

John D. Minna, Adi Gazdar, Joyce E. Ohm, Denise Juroske, Jonathan R. Pollack, Michael Peyton, Kiyoshi Yanagisawa, Yuhui Huang, Joseph Amann, J. Stuart Salmon, Hisayuki Shigematsu, David P. Carbone, Pierre P. Massion, Shailaja Kalyankrishna, Young H. Kim, Jonathan M. Kurie, Luc Girard, Aberrant epidermal growth factor receptor signaling and enhanced sensitivity to EGFR inhibitors in lung cancer Cancer Research. ,vol. 65, pp. 226- 235 ,(2005)

Peter Blume-Jensen, Tony Hunter, Oncogenic kinase signalling. Nature. ,vol. 411, pp. 355- 365 ,(2001) , 10.1038/35077225

G. J. Brunn, J. Williams, C. Sabers, G. Wiederrecht, J. C. Lawrence, R. T. Abraham, Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. The EMBO Journal. ,vol. 15, pp. 5256- 5267 ,(1996) , 10.1002/J.1460-2075.1996.TB00911.X

Trudey Nicklee, David W. Hedley, Sylvia S. W. Ng, Ming-Sound Tsao, Wortmannin inhibits pkb/akt phosphorylation and promotes gemcitabine antitumor activity in orthotopic human pancreatic cancer xenografts in immunodeficient mice. Clinical Cancer Research. ,vol. 7, pp. 3269- 3275 ,(2001)